Zimmer Biomet Holdings (ZBH) Reports In-Line Q3 EPS, Beats on Revenue; Offers FY24 EPS Guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.74, in-line with the analyst estimate of $1.74. Revenue for the quarter came in at $1.82 billion versus the consensus estimate of $1.8 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2024 EPS of $7.95-$8.05, versus the consensus of $7.95. Zimmer Biomet Holdings sees FY2024 revenue of $7.95 billion, versus $7.66 billion consensus.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• JPMorgan Downgrades Astral Ltd (ASTRA:IN) to Neutral
• GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing